Inhibition of the cyclin D1/E2F pathway by PCA‐4230, a potent repressor of cellular proliferation
David A. Goukassian(Mount Sinai Health System), Vicente Andrés(Centro de Investigación en Red en Enfermedades Cardiovasculares), Jesús M. Ureña(Universitat de Barcelona), Jaime Font de Mora(Bellvitge University Hospital), Ignacio Pérez‐Roger(Instituto de Biomedicina de Valencia), Silvia M. Sanz‐González(Universitat de València)
Cited by 8
Related Papers
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
|New England Journal of Medicine|2017|3.2k
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice
|Science|2017|1.5k
Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome
|Journal of the American College of Cardiology|2018|673
High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene
|Cancer Cell|2004|379
Telomere Biology and Cardiovascular Disease
|Circulation Research|2006|241